Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Exploratory Study on the Safety and Efficacy of YOLT-204 in the Treatment of Hemoglobinopathies (Sickle Cell Disease and Transfusion-Dependent Thalassemia)

NCT07774351 is registered in ClinicalTrials.gov with Union Hospital, Tongji Medical College, Huazhong University of Science and Technology as lead sponsor.

NCT NCT07774351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07774351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Exploratory Study on the Safety and Efficacy of YOLT-204 in the Treatment of Hemoglobinopathies (Sickle Cell Disease and Transfusion-Dependent Thalassemia)
Lead sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Not applicable
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
April 1, 2028
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemoglobinopathies